Eric Criscuolo | BiotechTV

top of page

NYSE Market Strategist Eric Criscuolo discusses biotech's newfound momentum and whether it might attract generalists to take a look at the sector

He discusses the rally biotech has had of late, and that was boosted by Pfizer's deal with the White House. Plus, how interest rates,...

Bright Minds

Oct 8

NYSE Strategist Eric Criscuolo shares his take on the markets and biotech sentiment

He discusses the importance of interest rates to high risk sectors like biotech, and comment on how our sector has not performed lately...

Bright Minds

Jul 22

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.

Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.

Learn more about Evaluate

bottom of page

NYSE Market Strategist Eric Criscuolo discusses biotech's newfound momentum and whether it might attract generalists to take a look at the sector

NYSE Strategist Eric Criscuolo shares his take on the markets and biotech sentiment

Follow BiotechTV

Sponsors

Sponsor Spotlight